Health Condition 1: J988- Other specified respiratory disorders
Conditions
Interventions
Intervention1: Chitraka Haritaki Avaleha: Dose of Chitraka Haritaki Avaleha will be given orally dose is gramm per year( Sharangadhara samhita), BID, with water for 42 days.
Control Intervention1: Chy
Sponsors
Datta Meghe Institute of Medical Science
Eligibility
Inclusion criteria
Inclusion criteria: Children of age 2 to 6 years of either sex, •Child with upper respiratory illness- Common cold, Sinusitis, Pharyngitis, UpperAirway disease. •Child having an atopic respiratory condition. •Child fulfilling the diagnostic criteria.
Exclusion criteria
Exclusion criteria: 1.A child with acute respiratory conditions; needs emergency management like Oxygen supplementation. 2.Child with congenital malformation. 3.Child with lower respiratory illness. 3Child of congenital heart disease. 4. Children with any life-threatening condition will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Preventive effects- prevention of the recurrence of upper respiratory tract infections. â?¢ Immunological effects- Promote host defence by enhancing immunity so that prevent recurrence of upper respiratory illness. â?¢ Weight gain- Trial drug have Agni dipana(increase digestive fire) property, by increasing appetite weight gain will be achieved. Timepoint: 8 to 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Quality of life]- (will be assessed according to Ayurvedic protocol) Trial drug have a Rasanana (rejuvenation) property and by enhancing immunity that will be stave of illness and restore the health of the child and will be improve quality of life.Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr Rekha Shinde
Datta Meghe Institute of Medical Science
Outcome results
None listed